<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28-vaccines-08-00174">
 <label>28.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gailhardou</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Skipetrova</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Dayan</surname>
    <given-names>G.H.</given-names>
   </name>
   <name>
    <surname>Jezorwski</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Saville</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Van Der Vliet</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Wartel</surname>
    <given-names>T.A.</given-names>
   </name>
  </person-group>
  <article-title>Safety overview of a recombinant live-attenuated tetravalent dengue vaccine: Pooled analysis of data from 18 clinical trials</article-title>
  <source>PLoS Negl. Trop. Dis.</source>
  <year>2016</year>
  <volume>10</volume>
  <elocation-id>e0004821</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pntd.0004821</pub-id>
  <pub-id pub-id-type="pmid">27414655</pub-id>
 </element-citation>
</ref>
